Das HAS? New French comparator plan echoes German reimbursement
This article was originally published in Scrip
Executive Summary
The French HTA agency, the HAS (Haute Autorité de Santé), has published details of a new "relative therapeutic index" mechanism that it plans to use to select medicines for reimbursement on the basis of a comparison with existing products.